Search results for #VaccinesInnovation
#VaccinesInnovation goes beyond prevention. New vaccines in development may be able to treat cancers such as glioblastoma, solid tumours, and skin cancer bit.ly/3RMagLU #WeWontRest #EWAC2023
.@AndreeaI24 at @EPSA_Online webinar: It's crucial that we adopt a lifelong approach to vaccination, to make sure everyone is protected against vaccine-preventable diseases #VaccinesInnovation
There are 100 vaccine candidates in development by our member companies using 10 different technology platforms, shares @AndreeaI24 at @EPSA_Online webinar #VaccinesInnovation
Europe needs to be ready for the innovative vaccines currently in development. Hear from @sibiliaquilici in conversation with @ITNBusiness about #VaccinesInnovation. Full interview coming soon #WeWontRest #AdvancingImmunology
This morning at an event organised by @APIFARMA_, @laurentlouette spoke about the crucial role #VaccinesInnovation plays in improving public health and protecting people against current and upcoming health challenges.
Diversifizierung der Impfstofftechnologien ist der Schlüssel, um eine Reihe von unterschiedlichen Krankheiten bekämpfen zu können! Oftmals ist die Wahlmöglichkeiten zwischen verschiedenen Impfstoffe für Impfentscheidung wichtig. #VaccinesInnovation #ImpfenNuetztImpfenSchuetzt
Diversifizierung der Impfstofftechnologien ist der Schlüssel, um eine Reihe von unterschiedlichen Krankheiten bekämpfen zu können! Oftmals ist die Wahlmöglichkeiten zwischen verschiedenen Impfstoffe für Impfentscheidung wichtig. #VaccinesInnovation #ImpfenNuetztImpfenSchuetzt
Diversification of vaccine technologies is key to addressing a range of diseases and ensuring people are provided with a choice of vaccines to meet their needs bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
It is estimated that 60% of infectious diseases in humans can be attributed to animal origin. Vaccines in the pipeline are targeting zoonotic infections such as those caused by coronaviruses, Ebola and Nipah bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Today, up to 20 infectious diseases can be prevented through routine immunisation. Vaccines in the pipeline can provide even greater protection against vaccine-preventable diseases bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Travelling can contribute to the spread of endemic infectious diseases. Travel vaccines in development against pathogens like Chikungunya virus or diseases like dengue fever can help address this challenge bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Therapeutic vaccines are still at an early stage but new vaccines in development can help treat cancer or chronic infections such as #HepatitisB bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Climate change is having a serious effect on global health. By developing vaccines against diseases like malaria and Zika virus disease, we can prepare now for cross-border health threats posed by climate change bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Vaccines are an important tool in the fight against #AMR. More than 10% of vaccines in Vaccines Europe members’ pipeline target antibiotic-resistant pathogens on the @WHO Priority Pathogens list bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Respiratory tract infections pose a significant challenge for adults. New vaccines in development can help reduce the economic and healthcare burden of respiratory diseases such as #flu, #RSV, #COVID19 and pneumococcal bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Adult immunisation improves quality of life, contributes to healthy ageing and can help address health inequalities. A life-course approach to vaccination is vital for building society’s resilience bit.ly/3RMagLU #WeWontRest #UnitedInProtection #VaccinesInnovation
Innovation in vaccine development goes beyond prevention. New vaccines may be able to treat cancers such as glioblastoma, solid tumours, and skin cancer bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
#VaccinesInnovation means not only tackling diseases for which there are currently no approved vaccines, but also further developing existing vaccines bit.ly/3RMagLU #WeWontRest
Innovative vaccines were instrumental for tackling the #COVID19 pandemic. 100 vaccines in development can help address existing and upcoming health threats bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Last December, we published the first-ever pipeline review of our members. Find out more about what vaccines are in development and how they’re addressing the health challenges of tomorrow bit.ly/3RMagLU #WeWontRest #VaccinesInnovation
Professor Lana Kandalaft, working at @OncoUNILCHUV and @Ludwig_Cancer, has launched several clinical trials to develop cancer vaccines based on personalised cell therapy, but challenges still lies ahead. Read her article about #VaccinesInnovation 👉 bit.ly/3QchGXs
